BioCardia announces acceptance of CardiAMP HF echocardiography data for late-breaking presentation at THT 2026

BioCardia, Inc.

Echocardiography data from CardiAMP HF trial accepted for Late Breaking Clinical Trial Oral Presentation at THT Meeting.
Presentation by Dr. Amish Raval, Professor of Medicine at UW School of Medicine and Public Health and CardiAMP HF National Co-PI.
THT meeting takes place March 2-4, 2026 in Boston, MA.
Title: 'Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics.'

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.